Mochida Pharmaceutical Co., Ltd.
Research Mochida Pharmaceutical Co., Ltd. (4534.T) on Bullrun: market cap JPY 115.03B, P/E 12.6, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4534.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 115.03B
- P/E12.6
- Dividend yield2.5%
- Financial periodFY2026
- RevenueJPY 116.95B
- Revenue growth11.2%
- Net incomeJPY 7.90B
- Free cash flow-JPY 10.05B
- Gross margin48.1%
Valuation Snapshot
latest market cap is JPY 115.03B; P/E is 12.6; dividend yield is 2.5%.
Peer valuation comparison
Latest P/E is 12.63x versus a Healthcare sector median of 21.69x (41.8% below).
Latest dividend yield is 2.54% versus a Healthcare sector median of 2.41% (5.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 116.95B | JPY 7.90B | -JPY 10.05B | 48.1% | 222.96 | JPY 28.06B | JPY 10.00B | JPY 140.32B |
| FY2025 | JPY 105.16B | JPY 5.69B | JPY 7.19B | 51.1% | 160.36 | JPY 45.15B | JPY 0 | JPY 130.69B |
| FY2024 | JPY 102.89B | JPY 4.55B | -JPY 9.78B | 50.6% | 126.8 | JPY 33.29B | n/a | JPY 127.97B |
| FY2023 | JPY 103.26B | JPY 6.65B | JPY 5.13B | 53.4% | 178.93 | JPY 47.01B | n/a | JPY 126.77B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 115.03B | 12.6 | 2.6% | 85 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 85 JPY, yield 2.5%.
| Year | Dividends/share |
|---|---|
| FY2026 | 82.5 JPY |
| FY2025 | 80 JPY |
| FY2024 | 80 JPY |
| FY2023 | 80 JPY |
| FY2022 | 90 JPY |
About Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. The company offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatologists, psychiatry, and gastroenterological, including Realda and Collagen for the treatment of ulcerative colitis; Goofis and Movicol for the treatment of chronic constipation; interstitial pulmonary hypertension for the treatment of pulmonary arterial hypertension;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mochida Pharmaceutical Co., Ltd.'s market cap?
Mochida Pharmaceutical Co., Ltd.'s market capitalization is JPY 115.03B.
What is Mochida Pharmaceutical Co., Ltd.'s P/E ratio?
Mochida Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 12.6.
Does Mochida Pharmaceutical Co., Ltd. pay a dividend?
Mochida Pharmaceutical Co., Ltd. has a dividend yield of 2.5%.
What does Mochida Pharmaceutical Co., Ltd. do?
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. The company offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatologists, psychiatry, and gastroenterological, including Realda and Collagen for the treatment of ulcerative colitis; Goofis and Movicol for the treatment of chronic constipation; interstitial pulmonary hypertension for the treatment of pulmonary arterial hypertension; Treprospermid, for pulmonary hypertension associated with ulcerative lung disease; Uris, for gout and.